Member Login
  1. Stocks
    2. /
  2. OXB (LSE: OXB)
    3. /

LSE:OXB (OXB)

About OXB

OXB is a quality and innovation-led contract development and manufacturing organisation (CDMO) in cell and gene therapy with a mission to enable its clients to deliver life changing therapies to patients around the world. OXB, a FTSE4Good constituent, is headquartered in Oxford, UK. It has bioprocessing and manufacturing facilities across Oxfordshire, UK, Lyon and Strasbourg, France and near Boston, MA, US.
Financial Market Data copyright © 2025 QuoteMedia. Data delayed 15 minutes unless otherwise indicated (view delay times for all exchanges). RT=Real-Time, EOD=End of Day, PD=Previous Day. Market Data powered by QuoteMedia. Terms of Use.

    • OXB (LSE: OXB) Latest News

    Investing Articles

    Will the Oxford Biomedica share price keep on climbing?

    | Zaven Boyrazian, MSc (TMFBoyrazian)

    The Oxford Biomedica share price is surging after extending its deal with AstraZeneca. Zaven Boyrazian investigates if this momentum can…

    Read more »

    Investing Articles

    Oxford Biomedica’s share price hits record peaks as it upgrades forecasts!

    | Royston Wild

    The Oxford Biomedica share price has roared to new all-time peaks as vaccine orders from AstraZeneca increase. Here are the…

    Read more »

    Investing Articles

    Want to be a millionaire? I’d follow Warren Buffett’s example and buy cheap shares

    | Zaven Boyrazian, MSc (TMFBoyrazian)

    Warren Buffett made his fortune in the stock market. Zaven Boyrazian explains how he did it, and how you can…

    Read more »

    Investing Articles

    Top British stocks for January 2021

    | The Motley Fool Staff

    We asked our freelance writers to share their top British stocks for January, including Rio Tinto, Safestore and IG Group.

    Read more »

    Investing Articles

    AstraZeneca’s Covid-19 vaccine approved! Here’s what I’d do now

    | Zaven Boyrazian, MSc (TMFBoyrazian)

    Approval for AstraZeneca’s vaccine brings the UK a step closer to winning the fight against Covid-19. But is there a…

    Read more »

    Investing Articles

    Covid-19 vaccine: 1 biotech stock that profits from AstraZeneca’s success

    | Zaven Boyrazian, MSc (TMFBoyrazian)

    Another Covid-19 vaccine may soon be available from AstraZeneca. Zaven Boyrazian analyses the results and finds a larger opportunity for…

    Read more »

    Investing Articles

    I’d buy these 2 growth stocks for explosive returns!

    | Zaven Boyrazian, MSc (TMFBoyrazian)

    Looking for top UK shares to buy now? These two biotech growth stocks have been generating explosive returns for many…

    Read more »

    Investing Articles

    Did Oxford Biomedica just find a new treatment for Parkinson’s disease?

    | Zaven Boyrazian, MSc (TMFBoyrazian)

    Zaven Boyrazian takes another look at Oxford Biomedica after promising results on its Parkinson’s disease treatment were announced.

    Read more »

    Investing Articles

    1 hidden growth stock I think can become a leader in this $14bn industry

    | Zaven Boyrazian, MSc (TMFBoyrazian)

    Biotech has become a powerful source of growth for big pharma. Zaven Boyrazian takes a closer look at a growth…

    Read more »

    Investing Articles

    This biotech growth stock has soared in the coronavirus pandemic. Here’s what you need to know

    | Alan Oscroft

    Here are two potential growth stocks, affected by Covid-19 in different ways. Their share prices have headed in opposite directions…

    Read more »

    Investing Articles

    I believe this coronavirus stock could be a great growth opportunity

    | Jabran Khan

    This Fool is interested in a coronavirus stock that could be a great opportunity for your portfolio on the back…

    Read more »

    Investing Articles

    Is the Thomas Cook share price a buy after 20% jump?

    | Alan Oscroft

    The Thomas Cook Group plc (LON: TCG) share price climbs in response to radical plans to turn the travel giant…

    Read more »